Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Hairong Pharmaceutical is a core subsidiary of the Yangzijiang Pharmaceutical Group, situated in Dujiangyan, Sichuan Province. The company is a comprehensive pharmaceutical enterprise that integrates research, development, and large-scale manufacturing of chemical drugs and modernized traditional Chinese medicines. Its product line covers several therapeutic areas, including gastroenterology, neurology, and cardiology, with a focus on high-quality generic and proprietary formulations. Sichuan Hairong operates state-of-the-art GMP-certified facilities and serves as a critical production base for the parent group's domestic operations. The company is recognized for its commitment to quality and innovation within the Chinese pharmaceutical landscape.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yangzijiang Pharmaceutical Sichuan Hairong Pharmaceutical.